Your cart is currently empty!
Palnox (Palonosetron) Injection
Generic brands for Palonosetron Injection Available in India Brand Name Palnox Generic Name Palonosetron Strength 0.25mg Manufacturer Glenmark Pharmaceuticals
Description
Description
This page contains brief details about the drug palonosetron, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Palonosetron is an antiemetic drug that belongs to the category of medicines known as alkylating agents. It was approved by the FDA in July 2003 to treat Chemotherapy induced nausea and vomiting.
Mechanism of Action of Palonosetron
Palonosetron is an Isoquinoline derivative that interacts with 5-HT3 receptor antagonists. It is a type of serotonin receptor antagonist, which works by blocking the action of serotonin in the body that induces nausea and vomiting.
Uses of Palonosetron
Palonosetron is an anti-emetic agent used to treat Postoperative nausea & vomiting. It is also used in the treatment of Chemotherapy induced nausea & vomiting.
Palonosetron Dosage available
Palonosetron is a prescription drug available only in tablet and injection form. The medicine will be administered to you by a qualified healthcare professional in a hospital setting. This injection will be given intravenously into a vein in your arm or hand. Do not self-administer this medicine. The dose of the injection will be decided by your doctor based on your disease condition and other factors. Palonosetron Hydrochloride Injection is usually given about 30 minutes before you receive your anti-cancer medicine (chemotherapy) or right before anaesthesia for surgery. If you are taking palonosetron as an oral tablet, it should be swallowed whole with a glass of water, with or without food, as directed by your healthcare provider. Do not crush, chew, or break the tablet before swallowing it.
We can ship to :
News/Updates
References
- Accord Healthcare SLU, Electronic medicines compendium (emc), [Revised on Feb 2021] [ Accessed on 01st March 2023], https://www.medicines.org.uk/emc/files/pil.7235.pdf
- Fresenius kabi, US Food and Drug Administration, [Revised on Dec 2018] [Accessed on 01st March 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208109s001lbl.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Treatment of disorders of bowel motility and water flux, 12th edition, 2011, 1341.
- KD Tripathi, Essentials of Medical Pharmacology, Antiemetic, prokinetic and digestant drugs, 7th edition, 2013, 669.